DEEP RESEARCH · ROCKET LAB
Rocket Lab: Ownership, Capital Structure, and Strategic Investment Analysis
Connecting founder preferred shares, ATM issuance, convertibles, and Geost/Mynaric deals to the Neutron strategy
0. Bottom line first
Rocket Lab is expanding from Electron's stable revenue base into Neutron, Space Systems, and national-security payloads. The source's key point is that Q3 2025 revenue of $155.1 million and $1.1 billion of backlog must be read together with the financing and dilution structure behind that growth.
This post builds on the earlier Rocket Lab analysis, overview of Rocket Lab, and focuses more deeply on ownership and capital structure.
Official fact: The source cites Q3 2025 revenue of $155.1 million, up 48% year over year, GAAP gross margin of 37.0%, non-GAAP gross margin of 41.9%, and backlog of $1.1 billion.
Interpretation: The growth is real, but 2025 ATM issuance, convertible-note conversion, and stock consideration for M&A all increase the share count. Investors need to track revenue growth and dilution per share together.
1. Founder control and insider sale plans
On December 3, 2024, Rocket Lab entered into a stock exchange agreement with The Equatorial Trust, Sir Peter Beck's family trust, and closed it on January 7, 2025. The trust returned 50,951,250 common shares and received the same number of Series A Convertible Participating Preferred Shares.
- The Series A preferred votes together with common stock and, at the current 1:1 conversion ratio, does not dilute Sir Peter Beck's voting power.
- It has no fixed dividend, but participates if common shareholders receive dividends.
- On June 17, 2025, the trust converted 5,000,000 preferred shares back into common stock.
| Insider | Role | Maximum sale shares | Possible start date |
|---|---|---|---|
| Adam Spice | CFO | 1,365,665 | 2026.01.05 |
| Frank Klein | COO | 425,000 | 2026.01.02 |
| Arjun Kampani | SVP legal | 132,519 | 2026.03.04 |
| Nina Armagno | Director | 38,240 | 2025.12.19 |
| Jon Olson | Director | 30,205 | 2025.12.19 |
| Merline Saintil | Director | 22,500 | 2025.12.17 |
2. ATM and convertibles: growth capital and dilution
| Program | Shares sold | Gross proceeds | Net proceeds |
|---|---|---|---|
| March 2025 ATM | 15,142,133 | $396.6M | $387.0M |
| September 2025 ATM | 9,591,839 | $468.8M | $458.1M |
| Total | 24,733,972 | $865.4M | $845.1M |
The 4.250% convertible senior notes issued in February 2024 total $355 million and mature in 2029. The initial conversion price was about $5.13, and in Q3 2025 the stock traded above 130% of that price for more than 20 trading days, triggering early conversion rights from October 1 to December 31, 2025. The source notes conversion requests for $192.02 million of notes after September 30, 2025 and issuance of 37,464,040 common shares.
3. Geost, Mynaric, and Neutron investment
$289.63M
Closed on August 12, 2025, bringing electro-optical/infrared sensor and national-security payload capability.
About $75M
September 2025 acquisition agreement aimed at internalizing inter-satellite laser communication terminals.
$106.63M
January to September 2025 capex, up 134% from $45.53 million in the prior-year period.
Geost consideration consists of $133.72 million cash, $137.65 million of stock consideration equal to 3,057,588 shares, and $18.25 million of contingent consideration. Mynaric is framed as a way to secure OISL capability required for next-generation constellations such as the SDA transport layer.
4. Results, backlog, and checkpoints
| Item | Q3 2025 | Q3 2024 | Change |
|---|---|---|---|
| Revenue | $155.1M | $104.8M | +48% |
| Gross profit | $57.3M | $28.0M | +105% |
| R&D | $70.7M | $47.7M | +48% |
| SG&A | $45.6M | $32.2M | +42% |
| Operating loss | $(59.0M) | $(51.9M) | loss continues |
- Backlog is $1.1 billion, split 59% Space Systems and 41% Launch.
- 57% of backlog is expected to convert to revenue within 12 months; 43% is longer-term.
- Q4 2025 guidance is revenue of $170 million to $180 million, GAAP gross margin of 37-39%, and adjusted EBITDA loss of $23 million to $29 million.
5. Risks I would track
- Neutron delay and cost overrun risk is central to valuation.
- ATM issuance, convertibles, and stock-funded M&A increase the share count.
- Government shutdowns or defense budget delays can push out revenue recognition for SDA and other government projects.
- Matt Ocko's November 30, 2025 board retirement symbolizes the move from early venture phase to mature public-company governance.
Sources
- Original blog: https://m.blog.naver.com/PostView.naver?blogId=star_of_self&logNo=224109526423
- Earlier analysis: https://blog.naver.com/star_of_self/224109372141
- _ROCKETLAB_Q3 2025 Earnings Presentation JpegSlides HR.pdf